NP
NPTH.V NeuPath Health Inc
- Market cap
- CAD 31.9M
- P/E
- 28.0x
- P/B
- 1.34x
- ROE
- 16.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is NPTH.V undervalued?
Graham numberNPTH.V trades 29.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NeuPath Health Inc fundamental analysis
No fundamental analysis for NeuPath Health Inc yet.
NeuPath Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care p…
Full company profileNeuPath Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
NeuPath Health Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | - | - | 49.6M | 47.6M | 60.9M | 62.7M | 66.1M | 72.8M | 87.2M | 89.5M |
| Gross Profit | - | - | 9.96M | 9.72M | 11.1M | 10.8M | 12.3M | 13.9M | 16.6M | 16.7M |
| Operating Income | - | - | -661K | -820K | -1.84M | -1.26M | 442K | 1.41M | 2.04M | 3.78M |
| EBITDA | - | - | -973K | -863K | 714K | -584K | 3.59M | 2.97M | 3.13M | 5.56M |
| Net Income | - | - | -5.31M | -5.06M | -3.23M | -4.17M | -107K | -728K | -717K | 3.81M |
| EPS | - | - | -0.19 | -0.12 | -0.07 | -0.08 | 0.00 | -0.01 | -0.01 | 0.07 |
| Balance Sheet | ||||||||||
| Total Assets | - | - | 38.0M | 46.1M | 51.3M | 45.1M | 41.8M | 41.3M | 45.1M | 46.6M |
| Total Liabilities | - | - | 28.2M | 18.5M | 25.5M | 23.4M | 19.9M | 19.9M | 24.1M | 23.2M |
| Shareholders' Equity | - | - | 9.77M | 27.6M | 25.8M | 21.8M | 22.1M | 21.4M | 20.6M | 22.9M |
| Cash & Short-term Investments | - | - | 883K | 10.9M | 5.90M | 1.52M | 3.18M | 2.92M | 4.47M | 3.51M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -3.38M | -2.13M | -986K | -646K | 1.92M | 738K | 3.03M | 2.61M | 4.00M | 1.41M |
| Capital Expenditure | 137K | 575K | 131K | 38.0K | 411K | 1.23M | 353K | 948K | 863K | 912K |
| Free Cash Flow | - | - | -1.12M | -747K | 1.17M | -934K | 2.68M | 1.66M | 3.14M | 494K |
| Ratios | ||||||||||
| ROE | - | - | -54.3% | -18.3% | -12.5% | -19.1% | -0.5% | -3.4% | -3.5% | 16.6% |
| ROA | - | - | -14.0% | -11.0% | -6.3% | -9.2% | -0.3% | -1.8% | -1.6% | 8.2% |
| Net Profit Margin | - | - | -10.7% | -10.6% | -5.3% | -6.6% | -0.2% | -1.0% | -0.8% | 4.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
NeuPath Health Inc dividends
NeuPath Health Inc has not paid dividends in the last 9 fiscal years.
Who owns NeuPath Health Inc
- Insiders 2.88%
- Institutions 10.84%
- Public & others 86.29%
- Shares outstanding 57.0M
- Free float 49.0M
NeuPath Health Inc company profile
- Company name
- NeuPath Health Inc
- Ticker
- NPTH.V
- ISIN
- CA64133P1009
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 152
- Fiscal year end
- December
- Address
- 110 Matheson Blvd West, Mississauga, ON, Canada, L5R 4G7
- Phone
- 905 858 1368
- Website
- neupath.com
About NeuPath Health Inc
NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and disability insurers, as well as legal practices through a network of health care providers comprising cardiologists, dentists, dermatologists, psychiatrists, endocrinologists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists. In addition, it operates a network of healthcare clinics and related businesses. The company is headquartered in Mississauga, Canada.
NeuPath Health Inc management
3- Mr. Stephen L. Lemieux BA, CPA, CA, MMPAChief Executive Officer · born 1977
- Mr. Jeff Zygouras C.A., CPACFO & Corporate Secretary
- Mr. Sandee Dela CruzChief Information Officer